Jakob Dupont

Company: Atara Biotherapeutics

Job title: Executive Vice President, Head of Global Research & Development

Seminars:

Accelerating Clinical Development of Off-the-Shelf Cell Therapy for Liquid and Solid Tumours 5:30 pm

Clinical and regulatory experience with Atara’s Phase 2 and Phase 3 allogeneic T-cell therapies Benefits of allogeneic approach and scaling manufacturing to meet patient needs How armouring next generation allogeneic T-cell immunotherapies can overcome the hostile tumour environmentRead more

day: Day 1 – Track B – Evening